Similar articles

• Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.

  Korporal M, Haas J, Balint B, Fritzsching B, Schwarz A, Moeller S, Fritz B, Suri-Payer E, Wildemann B. Korporal M, et al. Arch Neurol. 2008 Nov;65(11):1434-9. doi: 10.1001/archneur.65.11.1434. Arch Neurol. 2008. PMID: 19001161
• Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.

  Namdar A, Nikbin B, Ghabaee M, Bayati A, Izad M. Namdar A, et al. J Neuroimmunol. 2010 Jan 25;218(1-2):120-4. doi: 10.1016/j.jneuroim.2009.10.013. Epub 2009 Nov 22. J Neuroimmunol. 2010. PMID: 19932513
• Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.

  Chiarini M, Serana F, Zanotti C, Capra R, Rasia S, Rottoli M, Rovaris M, Caputo D, Cavaletti G, Frigo M, Frigeni B, Clerici R, Rezzonico M, Caimi L, Imberti L. Chiarini M, et al. Mult Scler. 2012 Jun;18(6):788-98. doi: 10.1177/1352458511427720. Epub 2011 Nov 15. Mult Scler. 2012. PMID: 22086901
• Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis.

  Farrell RA, Giovannoni G. Farrell RA, et al. Mult Scler. 2007 Jun;13(5):567-77. doi: 10.1177/1352458506073522. Epub 2007 Feb 16. Mult Scler. 2007. PMID: 17548434 Review.
• Current and future treatments for relapsing-remitting multiple sclerosis.

  Birnbaum G. Birnbaum G. Curr Opin Drug Discov Devel. 2010 Mar;13(2):214-25. Curr Opin Drug Discov Devel. 2010. PMID: 20205055 Review.